These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 18958661

  • 1. The Use of In Vitro Systems for Evaluating Immunotoxicity: The Report and Recommendations of an ECVAM Workshop.
    Gennari A, Ban M, Braun A, Casati S, Corsini E, Dastych J, Descotes J, Hartung T, Hooghe-Peters R, House R, Pallardy M, Pieters R, Reid L, Tryphonas H, Tschirhart E, Tuschl H, Vandebriel R, Gribaldo L.
    J Immunotoxicol; 2005 Apr 01; 2(2):61-83. PubMed ID: 18958661
    [Abstract] [Full Text] [Related]

  • 2. Eye Irritation Testing: The Way Forward. The Report and Recommendations of ECVAM Workshop 34.
    Balls M, Berg N, Bruner LH, Curren RD, de Silva O, Earl LK, Esdaile DJ, Fentem JH, Liebsch M, Ohno Y, Prinsen MK, Spielmann H, Worth AP.
    Altern Lab Anim; 1999 Apr 01; 27(1):53-77. PubMed ID: 25423402
    [Abstract] [Full Text] [Related]

  • 3. The Production of Polyclonal Antibodies in Laboratory Animals. The Report and Recommendations of ECVAM Workshop 35.
    Leenaars PP, Hendriksen CF, de Leeuw WA, Carat F, Delahaut P, Fischer R, Halder M, Hanly WC, Hartinger J, Hau J, Lindblad EB, Nicklas W, Outschoorn IM, Stewart-Tull DE.
    Altern Lab Anim; 1999 Apr 01; 27(1):79-102. PubMed ID: 25423403
    [Abstract] [Full Text] [Related]

  • 4. Recommendations of the ECVAM Workshop on "Alternatives to Animal Testing in the Quality Control of Immunobiologicals; State of the Art and Future Prospects".
    Hendriksen CF.
    ALTEX; 1994 Apr 01; 11(5):19-20. PubMed ID: 11178401
    [Abstract] [Full Text] [Related]

  • 5. The 3T3 neutral red uptake phototoxicity test: practical experience and implications for phototoxicity testing--the report of an ECVAM-EFPIA workshop.
    Ceridono M, Tellner P, Bauer D, Barroso J, Alépée N, Corvi R, De Smedt A, Fellows MD, Gibbs NK, Heisler E, Jacobs A, Jirova D, Jones D, Kandárová H, Kasper P, Akunda JK, Krul C, Learn D, Liebsch M, Lynch AM, Muster W, Nakamura K, Nash JF, Pfannenbecker U, Phillips G, Robles C, Rogiers V, Van De Water F, Liminga UW, Vohr HW, Wattrelos O, Woods J, Zuang V, Kreysa J, Wilcox P.
    Regul Toxicol Pharmacol; 2012 Aug 01; 63(3):480-8. PubMed ID: 22687423
    [Abstract] [Full Text] [Related]

  • 6. AGAATI/ECVAM Workshop on the Validation of Alternative Methods for the Potency Testing of Vaccines.
    Halder M, Hendriksen CF, Spieser JM.
    ALTEX; 1998 Aug 01; 15(5):5. PubMed ID: 11178524
    [Abstract] [Full Text] [Related]

  • 7. The ECVAM workshops: a critical assessment of their impact on the development, validation and acceptance of alternative methods.
    Combes RD.
    Altern Lab Anim; 2002 Dec 01; 30 Suppl 2():151-65. PubMed ID: 12513668
    [Abstract] [Full Text] [Related]

  • 8. Report of the EPAA-ECVAM workshop on the validation of Integrated Testing Strategies (ITS).
    Kinsner-Ovaskainen A, Maxwell G, Kreysa J, Barroso J, Adriaens E, Alépée N, Berg N, Bremer S, Coecke S, Comenges JZ, Corvi R, Casati S, Dal Negro G, Marrec-Fairley M, Griesinger C, Halder M, Heisler E, Hirmann D, Kleensang A, Kopp-Schneider A, Lapenna S, Munn S, Prieto P, Schechtman L, Schultz T, Vidal JM, Worth A, Zuang V.
    Altern Lab Anim; 2012 Jul 01; 40(3):175-81. PubMed ID: 22943518
    [Abstract] [Full Text] [Related]

  • 9. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
    Kirkland D, Pfuhler S, Tweats D, Aardema M, Corvi R, Darroudi F, Elhajouji A, Glatt H, Hastwell P, Hayashi M, Kasper P, Kirchner S, Lynch A, Marzin D, Maurici D, Meunier JR, Müller L, Nohynek G, Parry J, Parry E, Thybaud V, Tice R, van Benthem J, Vanparys P, White P.
    Mutat Res; 2007 Mar 30; 628(1):31-55. PubMed ID: 17293159
    [Abstract] [Full Text] [Related]

  • 10. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.
    De Wever B, Fuchs HW, Gaca M, Krul C, Mikulowski S, Poth A, Roggen EL, Vilà MR.
    Toxicol In Vitro; 2012 Apr 30; 26(3):526-34. PubMed ID: 22269383
    [Abstract] [Full Text] [Related]

  • 11. Lessons learned from validation of in vitro toxicity test: from failure to acceptance into regulatory practice.
    Spielmann H, Liebsch M.
    Toxicol In Vitro; 2001 Apr 30; 15(4-5):585-90. PubMed ID: 11566595
    [Abstract] [Full Text] [Related]

  • 12. ERGATT/ECVAM Workshop on Acceptance of Validated Alternative Methods: Amden III.
    Spielmann H, Liebsch M, Reinhardt C.
    ALTEX; 1998 Apr 30; 15(1):18-22. PubMed ID: 11208263
    [Abstract] [Full Text] [Related]

  • 13. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W, Dekant W, Foth H, Gebel T, Hengstler JG, Kahl R, Kramer PJ, Schweinfurth H, Wollin KM.
    Arch Toxicol; 2008 Apr 30; 82(4):211-36. PubMed ID: 18322675
    [Abstract] [Full Text] [Related]

  • 14. ECVAM and the Promotion of International Co-operation in the Development, Validation and Acceptance of Replacement Alternative Test Methods.
    Balls M.
    ALTEX; 1999 Apr 30; 16(4):280-282. PubMed ID: 11107329
    [Abstract] [Full Text] [Related]

  • 15. Implementation of three Rs alternatives in regulatory testing: possibilities and obstacles--the view of the validator.
    Halder M, Balls M.
    Dev Biol (Basel); 2002 Apr 30; 111():199-206. PubMed ID: 12678242
    [Abstract] [Full Text] [Related]

  • 16. Do we need a "Chair of alternative methods", and where?
    Wendel A.
    ALTEX; 2002 Apr 30; 19(2):64-8. PubMed ID: 12098011
    [Abstract] [Full Text] [Related]

  • 17. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE, Kleijnen J.
    Eur J Health Econ; 2008 Nov 30; 9 Suppl 1():5-29. PubMed ID: 18987905
    [Abstract] [Full Text] [Related]

  • 18. ECVAM's contributions to the implementation of the Three Rs in the production and quality control of biologicals.
    Halder M, Hendriksen C, Cussler K, Balls M.
    Altern Lab Anim; 2002 Nov 30; 30(1):93-108. PubMed ID: 11827574
    [Abstract] [Full Text] [Related]

  • 19. Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies.
    Coecke S, Goldberg AM, Allen S, Buzanska L, Calamandrei G, Crofton K, Hareng L, Hartung T, Knaut H, Honegger P, Jacobs M, Lein P, Li A, Mundy W, Owen D, Schneider S, Silbergeld E, Reum T, Trnovec T, Monnet-Tschudi F, Bal-Price A.
    Environ Health Perspect; 2007 Jun 30; 115(6):924-31. PubMed ID: 17589601
    [Abstract] [Full Text] [Related]

  • 20. Meeting report: Validation of toxicogenomics-based test systems: ECVAM-ICCVAM/NICEATM considerations for regulatory use.
    Corvi R, Ahr HJ, Albertini S, Blakey DH, Clerici L, Coecke S, Douglas GR, Gribaldo L, Groten JP, Haase B, Hamernik K, Hartung T, Inoue T, Indans I, Maurici D, Orphanides G, Rembges D, Sansone SA, Snape JR, Toda E, Tong W, van Delft JH, Weis B, Schechtman LM.
    Environ Health Perspect; 2006 Mar 30; 114(3):420-9. PubMed ID: 16507466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.